NEW YORK (GenomeWeb News) – Australian bioseparations products firm NuSep today said that it has signed a letter of intent to acquire US-based mass spectrometry software development firm BioInquire for more than $3 million.

NuSep also said that it has closed a private placement of its shares, raising $830,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.